Gene expression profiling for targeted cancer treatment

Anton Yuryev1

  • 1Elsevier, Inc. , 5635 Fishers Lane, Rockville, MD 20852 USA a.yuryev@elsevier.com.

Abstract

Insights

Causal reasoning algorithms offer a solution to the curse of dimensionality in cancer gene expression analysis. This approach transforms microarray data into cancer pathway activity, optimizing signature calculations.

Area of Science:

  • Bioinformatics
  • Computational Biology
  • Cancer Research

Background:

  • Microarray gene expression data analysis in cancer is hampered by the 'curse of dimensionality'.
  • This arises from limited sample sizes in training sets for calculating transcriptional signatures from numerous differentially expressed genes.
  • Existing methods face challenges in accurately identifying cancer-related gene expression patterns.

Purpose of the Study:

  • To address the limitations of current microarray data analysis in cancer research.
  • To introduce causal reasoning algorithms as a novel approach for analyzing gene expression data.
  • To optimize the calculation of transcriptional signatures by reducing data dimensionality.

Main Methods:

  • Reviewing current frustrations with transcriptional signatures derived from differentially expressed genes.
  • Overviewing novel signature calculation methods using differentially variable genes and expression regulators.
  • Exploring causal reasoning algorithms that leverage prior knowledge of regulatory events.

Main Results:

  • Causal reasoning algorithms can transform high-dimensional microarray data into the activity of a limited number of cancer hallmark pathways.
  • This transformation optimizes feature space dimensionality for accurate mathematical signature calculations.
  • Identifies expression regulators responsible for differential expression in cancer samples.

Conclusions:

  • Advocates for the use of causal reasoning methods to calculate cancer pathway activity signatures.
  • Highlights the need for high-quality knowledgebases and statistical algorithms for transforming expression regulator activity into pathway activity.
  • Emphasizes the potential of causal reasoning for advancing cancer research.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
6.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
80